Evidence map›Paper›PMID 31249955›Full record

ArticleTH open : companion journal to thrombosis and haemostasis2018

Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands: Clinical and Economic Effects.

Lisa A de Jong, Judith J Gout-Zwart, Jelena Stevanovic, Harrie Rila, Mike Koops, Menno V Huisman, Maarten J Postma

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in TH open : companion journal to thrombosis and haemostasis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Successful Treatment of Recurrent Thrombosis Associated with Malignancy with Apixaban and Follow-up for 1 Year.The International journal of angiology : official publication of the International College of Angiology, Inc · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lisa A de JongUnit of PharmacoTherapy, PharmacoEpidemiology and PharmacoEconomics (PTE2), University of Groningen, Groningen, The Netherlands.
Judith J Gout-ZwartUnit of PharmacoTherapy, PharmacoEpidemiology and PharmacoEconomics (PTE2), University of Groningen, Groningen, The Netherlands.
Jelena StevanovicBristol Myers Squibb, Utrecht, The Netherlands.
Harrie RilaBristol Myers Squibb, Utrecht, The Netherlands.
Mike KoopsUnit of PharmacoTherapy, PharmacoEpidemiology and PharmacoEconomics (PTE2), University of Groningen, Groningen, The Netherlands.
Menno V HuismanDepartment of Thrombosis and Hemostasis, Leiden University Medical Centre (LUMC), Leiden, The Netherlands.
Maarten J PostmaUnit of PharmacoTherapy, PharmacoEpidemiology and PharmacoEconomics (PTE2), University of Groningen, Groningen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

apixabancost-effectivenesslifelong treatmentnon–vitamin K oral anticoagulantsvenous thrombosis

Identifiers

PMID31249955
PMCPMC6524888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.